Pharmaceutical News

RSS

Drug shortages a new way of life in providing care; Lawmakers call for investigation

As health care facilities struggle to keep inventories of key medicines, some are resorting to risky practices. Meanwhile, six members of Congress seek GAO probe of pharmaceutical contracting so see if it has hurt generic drugmakers and added to shortages.

20 Nov 2012

Inspiration, Ipsen receive FDA Fast Track designation for OBI-1 to treat AHA

Ipsen and Inspiration Biopharmaceuticals Inc. today announced that Inspiration has received Fast Track designation from the US Food and Drug Administration (FDA) for OBI-1 in acquired hemophilia A.

20 Nov 2012

Finnish researchers develop triumphant solution to predict breast cancer cells’ responses to drugs

The answer is yes. Finnish researchers have developed a triumphant solution for predicting responses of breast cancer cells to a set of cancer drugs. The prediction is based on the genomic profiles of the cancer cells. Harnessing genomic profiles of cells in choosing the best treatment is considered the holy grail of personalised medicine.

20 Nov 2012

Hebron introduces Florax DS Diarrhea Relief and Ready-to-Drink probiotic

Hebron U.S.A. Corp. is introducing their Florax DS product line featuring a Ready-to-Drink probiotic, for digestive and immune support and an all-natural probiotic diarrhea relief product that provides relief of occasional diarrhea, cramping, gas and bloating without the use of harsh chemicals.

20 Nov 2012

Boston and Cincinnati Children's Hospital to learn more about how autism develops

A network of five leading medical centers, led by Cincinnati Children's Hospital Medical Center and Boston Children's Hospital, has received a five-year, $12.5 million National Institutes of Health (NIH) grant to learn more about how autism develops.

20 Nov 2012

Janssen receives positive opinion from EMA CHMP for ZYTIGA to treat mCRPC

Janssen-Cilag International NV (Janssen) announced today that the Committee for Medical Products for Human Use (CHMP) of the European Medicines Agency (EMA) has granted a positive opinion recommending approval of the oral, once-daily medication ZYTIGA for use in combination with prednisone or prednisolone in the treatment of metastatic castration-resistant prostate cancer (mCRPC), in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy and in whom chemotherapy is not yet clinically indicated.

19 Nov 2012

GSK receives FDA approval for PROMACTA to treat thrombocytopenia

GlaxoSmithKline plc announced today that the U.S. Food and Drug Administration (FDA) has approved PROMACTA for the treatment of thrombocytopenia (low blood platelet counts) in patients with chronic hepatitis C to allow them to initiate and maintain interferon-based therapy.

19 Nov 2012

KemPharm announces successful Type B meeting with FDA for KP201

KemPharm, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain, announced today a successful Type B meeting with the Food and Drug Administration (FDA) for its lead pain candidate, KP201.

19 Nov 2012

GVK Biosciences receives AERB approvals to carry out 3H and 14C synthesis activities

GVK Biosciences, Asia's leading Drug Discovery Research & Development organization, has received approvals from the Atomic Energy Regulatory Board (AERB), Government of India, to carry out 3H and 14C synthesis activities.

19 Nov 2012

Zolpidem associated with increased risk of falls

A drug commonly prescribed to help patients sleep in hospitals has been associated with an increased risk of falls, according to a study published in the Journal of Hospital Medicine.

19 Nov 2012

FDA accepts Orexo’s Zubsolv NDA for review

FDA has informed Orexo that the Zubsolv New Drug Application (NDA) has been accepted for review, and that the Prescription Drug User Fee Act (PDUFA) action date will be July 6, 2013.

19 Nov 2012

Marinomed’s Antiviral polymer awarded Chinese patent

Marinomed Biotechnologie GmbH, a company focused on the development of innovative therapies for respiratory diseases, today announced that it has been granted Chinese Patent No. CN101678040, entitled 'Antiviral polymer', by the Chinese patent office.

18 Nov 2012

Summit looks at the growing problem of prescription drug abuse

Today, a not-for-profit organization presenting at the Delaware Prescription Drug Abuse Summit appealed to the event's host, Attorney General Beau Biden, for assistance in preventing medication overdoses.

17 Nov 2012

MusculoskeletalNetwork features special coverage of sessions from ACR annual meeting

UBM Medica US announces that MusculoskeletalNetwork features special coverage of sessions from the annual meeting of the American College of Rheumatology (ACR), including the latest information about new FDA processes for approval of biosimilars that are like generic versions of expensive medications now used to treat painful rheumatologic conditions such as rheumatoid arthritis (RA).

17 Nov 2012

Personality traits linked with individual's susceptibility to placebo effect from pain medicines

Personality traits might do more than help you win a popularity contest. According to new University of Michigan-led neuroscience research, co-authored by University of Maryland (UM) School of Dentistry Dean Christian S. Stohler, DMD, DrMedDent, such traits also might make you more likely to get pain relief from a placebo - a fake medicine.

17 Nov 2012

HCV medications' side effects can now be replicated and observed in Petri dishes and test tubes

The adverse side effects of certain hepatitis C medications can now be replicated and observed in Petri dishes and test tubes, thanks to a research team led by Craig Cameron, the Paul Berg Professor of Biochemistry and Molecular Biology at Penn State University.

17 Nov 2012

Study reveals significant regional variation and trends in antibiotic use between 1999-2010

Research revealed during "Get Smart Week" shows that California joined Alaska, Hawaii, Oregon and Washington as the five states with the lowest antibiotic use in the nation in 2010.

17 Nov 2012

Study examines public health impact of tamper resistant extended-release oxycodone

This is the first epidemiological study to examine the public health impact of a tamper resistant extended-release oxycodone (ORF). ER oxycodone was reformulated with physicochemical barriers to crushing and dissolving intended to reduce abuse through non-oral routes of administration.

16 Nov 2012

Arginine and proline supplementation favor wound healing in diabetic rats

Chronic wounds such as foot ulcers are a common problem for diabetics and are the cause of more than 80 percent of the lower leg amputations in these patients. There is currently no effective way to improve healing of these types of wounds, but new research offers hope.

16 Nov 2012

CLR01 effectively inhibits synaptotoxicity in mice with Alzheimer's

Last March, researchers at UCLA reported the development of a molecular compound called CLR01 that prevented toxic proteins associated with Parkinson's disease from binding together and killing the brain's neurons.

16 Nov 2012

Pharmaceutical News

Drug shortages a new way of life in providing care; Lawmakers call for investigation

Inspiration, Ipsen receive FDA Fast Track designation for OBI-1 to treat AHA

Finnish researchers develop triumphant solution to predict breast cancer cells’ responses to drugs

Hebron introduces Florax DS Diarrhea Relief and Ready-to-Drink probiotic

Boston and Cincinnati Children's Hospital to learn more about how autism develops

Janssen receives positive opinion from EMA CHMP for ZYTIGA to treat mCRPC

GSK receives FDA approval for PROMACTA to treat thrombocytopenia

KemPharm announces successful Type B meeting with FDA for KP201

GVK Biosciences receives AERB approvals to carry out 3H and 14C synthesis activities

Zolpidem associated with increased risk of falls

FDA accepts Orexo’s Zubsolv NDA for review

Marinomed’s Antiviral polymer awarded Chinese patent

Summit looks at the growing problem of prescription drug abuse

MusculoskeletalNetwork features special coverage of sessions from ACR annual meeting

Personality traits linked with individual's susceptibility to placebo effect from pain medicines

HCV medications' side effects can now be replicated and observed in Petri dishes and test tubes

Study reveals significant regional variation and trends in antibiotic use between 1999-2010

Study examines public health impact of tamper resistant extended-release oxycodone

Arginine and proline supplementation favor wound healing in diabetic rats

CLR01 effectively inhibits synaptotoxicity in mice with Alzheimer's

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News